Clinical trials
Lymphoma trials in the United Kingdom with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 5 |
| Lymphoma Trials Office | 4 |
| University College, London | 3 |
| Children's Cancer and Leukaemia Group | 2 |
| Scotland and Newcastle Lymphoma Group | 2 |
| Chelsea and Westminster NHS Foundation Trust | 1 |
| Clatterbridge Centre for Oncology | 1 |
| European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | 1 |
| Lymphoma Study Association | 1 |
| Medical Research Council | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 30 |
| Lymphoma, Follicular | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Hodgkin Disease | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Leukemia | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, Large-Cell, Immunoblastic | 4 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.